Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/48857, first published .
Varenicline Combined With Oral Nicotine Replacement Therapy and Smartphone-Based Medication Reminders for Smoking Cessation: Feasibility Randomized Controlled Trial

Varenicline Combined With Oral Nicotine Replacement Therapy and Smartphone-Based Medication Reminders for Smoking Cessation: Feasibility Randomized Controlled Trial

Varenicline Combined With Oral Nicotine Replacement Therapy and Smartphone-Based Medication Reminders for Smoking Cessation: Feasibility Randomized Controlled Trial

Munjireen Sifat   1, 2 , BSc, MPH, PhD ;   Emily T Hébert   3 , DrPH ;   Jasjit S Ahluwalia   4 , MD ;   Michael S Businelle   1, 5 , PhD ;   Joseph J C Waring   6 , MPH ;   Summer G Frank-Pearce   1, 7 , PhD ;   Chase Bryer   4 , MSW ;   Lizbeth Benson   1 , PhD ;   Stefani Madison   5 , MD ;   Lourdes G Planas   8 , PhD ;   Irina Baranskaya   9 , MD ;   Darla E Kendzor   1, 5 , PhD

1 Tobacco Settlement Endowment Trust Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States

2 Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States

3 School of Public Health, The University of Texas Health Science Center, Austin, TX, United States

4 Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, United States

5 Department of Family and Preventive Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States

6 Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States

7 Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States

8 Department of Pharmacy: Clinical and Administrative Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States

9 Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States

Corresponding Author:

  • Munjireen Sifat, BSc, MPH, PhD
  • Tobacco Settlement Endowment Trust Health Promotion Research Center
  • Stephenson Cancer Center
  • University of Oklahoma Health Sciences Center
  • 655 Research Parkway, Suite 400
  • Oklahoma City, OK, 73104
  • United States
  • Phone: 1 215-955-8874
  • Email: mys519@jefferson.edu